Samsung's $73 Billion AI Gambit and a Genetics Bet: Navigating a 14% Stock Slide
11.06.2026 - 06:25:03 | boerse-global.de
Samsung Electronics is pouring record sums into artificial intelligence and quietly expanding into biotechnology, even as its shares suffer a sharp correction. The stock closed at 302,500 KRW on Wednesday, shedding roughly 6% in a single session and dragging its seven-day decline to nearly 14%. The rout reflects a broader exodus from tech stocks on the Korean exchange, where foreign investors have been pulling capital for weeks amid geopolitical jitters and a global rotation out of the sector.
Despite the sell-off, Samsung’s year-to-date gain still stands at a robust 135% — a testament to the earlier rally driven by its memory-chip dominance and AI ambitions. The 52-week low of 56,900 KRW is a distant memory, though the stock now sits about 18% below its all-time high of 370,000 KRW reached in early June. Much of the current weakness is attributed to market-wide sentiment rather than company-specific troubles.
A Twin-Track Strategy: AI Chips and Genomics
Management is betting big on two unrelated but potentially transformative frontiers. On the semiconductor side, Samsung has deepened its relationship with Nvidia. Chip chief Jun Young-hyun and Nvidia CEO Jensen Huang have expanded talks to cover the future HBM5 standard, signaling a partnership that stretches well beyond the current product cycle. Samsung has already begun shipping HBM4E samples — a global first — and is positioning itself to supply stable volumes of HBM4 and HBM4E for Nvidia’s forthcoming Vera-Rubin platform. Separately, Samsung’s foundry division will produce LP30 chips for the Nvidia-backed AI startup Groq, with manufacturing slated to start in the second half of 2026.
The foundry business itself is showing signs of a turnaround. Its 2-nanometer gate-all-around process achieved a yield above 60% in the first quarter, and analysts expect the segment to return to profitability as early as the third quarter of 2026.
Should investors sell immediately? Or is it worth buying Samsung Electronics?
On an entirely different front, Samsung has invested $175 million in Element Biosciences, a U.S. company specializing in DNA sequencing, becoming its largest shareholder. The plan is to combine genomic data with Samsung’s own artificial intelligence capabilities and integrate them into wearable devices such as the Galaxy Watch, with the ultimate goal of delivering personalized preventive medicine. That move marks the conglomerate’s first major foray into biotech beyond its existing biosimilar business.
Record Spending and a New Hub in Gwangju
To fund its AI-chip ambitions, Samsung is committing more than 110 trillion KRW (approximately $73 billion) in 2026, a 22% increase from the prior year. The bulk of that capital is earmarked for AI memory production, research, and advanced packaging. One key project is a new semiconductor packaging plant in Gwangju, a city in southwestern Korea chosen partly for its access to renewable energy — a growing priority for energy-intensive chip fabrication. The company is expected to make a final decision on the facility this summer.
The existing production clusters in Yongin and Pyeongtaek are reaching capacity, making the Gwangju expansion a strategic necessity. Meanwhile, Chairman Jay Y. Lee has been building European ties, holding talks in Italy about potential collaborations with STMicroelectronics and Ferrari in automotive chips and OLED displays.
Samsung Electronics at a turning point? This analysis reveals what investors need to know now.
What’s Next for the Stock
With the shares in retreat, traders are turning their attention to the 50-day moving average, currently at around 250,700 KRW. If that level holds, the longer-term uptrend remains intact despite the current correction. The broader market’s health will also be a factor: Korea’s stock exchange saw safety mechanisms triggered on four consecutive trading days, reflecting extreme volatility tied to Middle East tensions.
For now, Samsung is balancing a high-stakes AI push with an unexpected biotech pivot, while its share price digests a punishing week. The narrative is richer than a simple earnings story — and the market is still deciding how to price it.
Ad
Samsung Electronics Stock: New Analysis - 11 June
Fresh Samsung Electronics information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
